Hepatocellular adenomas: recent updates

키워드

참고문헌 (44)

1. Hepatocellular adenoma, In WHO classification of tumours: digestive system tumours, "Bioulac-Sage P", International Agency for Research on Cancer, 224~228 (2019)
2. Lin H, "Systematic review of hepatocellular adenoma in China and other regions", J Gastroenterol Hepatol, 26, pp.28~35 (2011)
3. Sasaki M, "Characterization of hepatocellular adenoma based on the phenotypic classification : the Kanazawa experience", Hepatol Res, 41, pp.982~988 (2011)
4. Sasaki M, "Overview of hepatocellular adenoma in Japan", Int J Hepatol, 2012, pp.648131~ (2012)
5. Liu HP, "Unique genetic alterations and clinicopathological features of hepatocellular adenoma in Chinese population", Pathol Res Pract, 211, pp.918~924 (2015)
6. Huang WC, "Hepatocellular adenoma in Taiwan : distinct ensemble of male predominance, overweight", obesity, and inflammatory subtype, 2020, pp.35, 680~688
7. Zucman-Rossi J, "Genotype-phenotype correlation in hepatocellular adenoma : new classification and relationship with HCC", Hepatology, 43, pp.515~524 (2006)
8. Nault JC, "Hepatocellular benign tumors-from molecular classification to personalized clinical care", Gastroenterology, 144, pp.888~902 (2013)
9. Scoazec JY, "Hepatocellular adenomas : one step beyond", Gut, 68, pp.1140~1142 (2019)
10. Nault JC, "Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation", Gastroenterology, 152, pp.880~894 (2017)
11. Nault JC, "Molecular classification of hepatocellular adenomas", Int J Hepatol, 2013, pp.315947~ (2013)
12. 신진호, "C-reactive Protein Overexpression in the Background Liver of Hepatitis B Virus–Associated Hepatocellular Carcinoma Is a Prognostic Biomarker", Journal of Pathology and Translational Medicine, 52(5), pp.267~274 (2018), 대한병리학회[DOI]
13. Rebouissou S, "Genotype-phenotype correlation of CTNNB1 mutations reveals different β-catenin activity associated with liver tumor progression", Hepatology, 64, pp.2047~2061 (2016)
14. Pilati C, "Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation", Cancer Cell, 25, pp.428~441 (2014)
15. Mounajjed T, "Pigmented hepatocellular adenomas have a high risk of atypia and malignancy", Mod Pathol, 28, pp.1265~1274 (2015)
16. Bioulac-Sage P, "Hepatocellular adenoma : classification, variants and clinical relevance", Semin Diagn Pathol, 34, pp.112~125 (2017)
17. Cappellen D, "A difficult case of betacatenin-mutated hepatocellular adenoma : a lesson for diagnosis", Histopathology, 74, pp.355~357 (2019)
18. Ibarrola C, "Focal hyperplastic hepatocellular nodules in hepatic venous outflow obstruction : a clinicopathological study of four patients and 24 nodules", Histopathology, 44, pp.172~179 (2004)
19. Paradis V, "Congenital hepatic fibrosis with multiple HNF1alpha hepatocellular adenomas", Clin Res Hepatol Gastroenterol., 38, pp.e115~e116 (2014)
20. 이양규, "Multiple hepatocyte nuclear factor 1A (HNF1A)-inactivated hepatocellular adenomas arising in a background of congenital hepatic fibrosis", Journal of Pathology and Translational Medicine, 55(2), pp.154~158 (2021), 대한병리학회[DOI]
21. Sempoux C, "Hepatocellular nodules in vascular liver diseases", Virchows Arch, 473, pp.33~44 (2018)
22. Frulio N, "Unclassified hepatocellular adenoma expressing ASS1 associated with inflammatory hepatocellular adenomas", Clin Res Hepatol Gastroenterol., 43, pp.e63~e67 (2019)
23. Henriet E, "Argininosuccinate synthase 1(ASS1) : a marker of unclassified hepatocellular adenoma and high bleeding risk", Hepatology, 66, pp.2016~2028 (2017)
24. Nault JC, "Argininosuccinate synthase 1and periportal gene expression in sonic hedgehog hepatocellular adenomas", Hepatology, 68, pp.964~976 (2018)
25. Sala M, "ASS1 overexpression : a hallmark of sonic Hedgehog hepatocellular adenomas : recommendations for clinical practice", Hepatol Commun, 4, pp.809~824 (2020)
26. Singhi AD, "Reticulin loss in benign fatty liver : an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma", Am J Surg Pathol, 36, pp.710~715 (2012)
27. Kim H, "Role of biopsy sampling for diagnosis of early and progressed hepatocellular carcinoma", Best Pract Res Clin Gastroenterol, 28, pp.813~829 (2014)
28. Di Tommaso L, "The application of markers(HSP70 GPC3 and GS)in liver biopsies is useful for detection of hepatocellular carcinoma", J Hepatol, 50, pp.746~754 (2009)
29. Lagana SM, "Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma", Appl Immunohistochem Mol Morphol, 21, pp.170~176 (2013)
30. Choi WT, "Atypical hepatocellular neoplasms : review of clinical, morphologic, immunohistochemical, molecular, and cytogenetic features", Adv Anat Pathol, 25, pp.254~262 (2018)
31. Evason KJ, "Atypical hepatocellular adenoma-like neoplasms with beta-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas", Hum Pathol, 44, pp.750~758 (2013)
32. Kakar S, "Well-differentiated hepatocellular neoplasm of uncertain malignant potential : proposal for a new diagnostic category : reply", Hum Pathol, 45, pp.660~661 (2014)
33. Roncalli M, "Benign hepatocellular nodules of healthy liver : focal nodular hyperplasia and hepatocellular adenoma", Clin Mol Hepatol, 22, pp.199~211 (2016)
34. Laumonier H, "Focal nodular hyperplasia with major sinusoidal dilatation:a misleading entity", BMJ Case Rep, 2010, pp.bcr0920103~ (2010)
35. Paradis V, "Telangiectatic focal nodular hyperplasia : a variant of hepatocellular adenoma", Gastroenterology, 126, pp.1323~1329 (2004)
36. Bioulac-Sage P, "Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver", Gastroenterology, 128, pp.1211~1218 (2005)
37. Bioulac-Sage P, "Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes", Am J Surg Pathol, 36, pp.1691~1699 (2012)
38. Joseph NM, "Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma", Mod Pathol, 27, pp.62~72 (2014)
39. Agostini-Vulaj D, "Distinction between inflammatory hepatocellular adenoma and mass effect on liver sampling", Hum Pathol, 61, pp.105~110 (2017)
40. Kim H, "Loss of liver fatty acid binding protein expression in hepatocellular carcinomas is associated with a decreased recurrence-free survival", J Liver Cancer, 15, pp.30~35 (2015)
41. Liu L, "Immunostains used to subtype hepatic adenomas do not distinguish hepatic adenomas from hepatocellular carcinomas", Am J Surg Pathol, 40, pp.1062~1069 (2016)
42. Torbenson M, "Hepatic adenomas : classification, controversies, and consensus", Surg Pathol Clin, 11, pp.351~366 (2018)
43. Sasaki M, "A serum amyloid A-positive hepatocellular neoplasm arising in alcoholic cirrhosis : a previously unrecognized type of inflammatory hepatocellular tumor", Mod Pathol, 25, pp.1584~1593 (2012)
44. Di Tommaso L, "Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis", Hepatology, 45, pp.725~734 (2007)

관련 논문AI추천